Galera Therapeutics, Reducing Toxicity & Increasing Anti-Cancer Efficacy for Patients Transcript
Now the interview is part of our WuXi AppTec thought leadership series, Innovation That Matters. And we seek -- incept perspectives from key opinion leaders and industry executives such as yourself. Our series focuses on novel and newsworthy advances and bringing transformative medicines to patients, the impact of collaborations and partnerships, use of new technologies on the horizon, and final thoughts on the future outlook of our industry.
And it's a pleasure for me to introduce and interview you, Robert, as a co-founder of Galera and where you've served as Chief Operating Officer since 2015. The company is focused on aspects of radiotherapy treatment, looking at dismutase mimetics to reduce oral mucositis and also for increasing the efficacy of radiotherapy.
Questions & Answers
And so the first topic that I'd like to introduce to you is that, in today's world of cancer therapies, how does radiotherapy fit into
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
